American International Group, Inc. Humanigen, Inc Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.76 - $3.33 $42,639 - $80,675	-24,227 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.81 - $3.97 $3,086 - $6,768	-1,705 Reduced 6.57%	24,227 $73,000
Q4 2021 Feb 11, 2022	BUY	$3.66 - $8.22 $3,916 - $8,795	1,070 Added 4.3%	25,932 $96,000
Q3 2021 Nov 12, 2021	SELL	$5.93 - $17.83 $1,601 - $4,814	-270 Reduced 1.07%	24,862 $147,000
Q2 2021 Aug 13, 2021	BUY	$13.54 - $22.74 $340,287 - $571,501	25,132 New	25,132 $437,000

558K

Ticker HGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,661,000
Description
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.